病因/危险因素证据 更多

• Impact of Diabetes Mellitus on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: A Meta-Analysis
• Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia
• Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
• Prevalence and risk factors of incidental prostate cancer in certain surgeries for benign prostatic hyperplasia: A systematic review and meta-analysis
• Nonalcoholic fatty liver disease and risk of prostatic diseases: Roles of insulin resistance

诊断证据 更多

• Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms

治疗及预后证据 更多

• Incidence, predictive factors and oncological outcomes of incidental prostate cancer after endoscopic enucleation of the prostate: a systematic review and meta-analysis
• Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging
• Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction
• Emerging outcomes of water vapor thermal therapy (Rezum) in a broad range of patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review
• The efficacy and safety of desmopressin acetate applied for nocturia in benign prostatic hyperplasia patients: A systematic review and meta-analysis

预防证据 更多

临床路径 更多

• 良性前列腺增生经尿道前列腺等离子电切术临床路径（2019年版）
• 良性前列腺增生经尿道前列腺电切术临床路径（2019年版）

临床实践指南 更多

• Management of Non-neurogenic Male Lower Urinary Tract Symptoms (LUTS)
• Management of Benign Prostatic Hyperplasia/ Lower Urinary Tract Symptoms: AUA Guideline
• Hong Kong Geriatrics Society and Hong Kong Urological Association consensus on personalised management of male lower urinary tract symptoms in the era of multiple co-morbidities and polypharmacy
• The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)
• Benign Prostatic Hyperplasia Guideline (SCU 2021)